Literature DB >> 11439144

Non-Th2 regulatory T-cell control of Th1 autoimmunity.

J F Bach1.   

Abstract

The Th1/Th2 concept brought an attractive explanation of the active self tolerance which appears to control the onset of pathogenic autoimmunity. New data coming from various independent horizons indicate that self immunoregulation could also depend to a large extent on non-Th2 cells. Original data derived from the day-3-thymectomy model, selective T-cell lymphocytopenia and nonobese diabetic mice are discussed in an effort to analyze similarities and differences in phenotype (CD25, CD62L and CD45RB) and cytokine pattern (notably interleukin (IL)-4, IL-10 and transforming growth factor (TGF)beta) of regulatory cells involved in these models. The relationship of these cells with Th3, Tr1 and natural killer (NK) T cells are also discussed. The hypothesis is proposed that CD25 CD62L T cells mediate the physiologic regulation of self regulation whereas Th2 and Th3 cells are essentially induced following sensitization against autoantigens.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11439144     DOI: 10.1046/j.1365-3083.2001.00945.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  7 in total

1.  Inflammatory Bowel Disease: Future Therapies.

Authors:  Sander J.H. Van Deventer
Journal:  Curr Treat Options Gastroenterol       Date:  2002-06

2.  Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis.

Authors:  Anne L Astier; Gregory Meiffren; Samuel Freeman; David A Hafler
Journal:  J Clin Invest       Date:  2006-11-09       Impact factor: 14.808

3.  Relationship between serum levels of IL-18 and IgG1 in patients with primary Sjögren's syndrome, rheumatoid arthritis and healthy controls.

Authors:  P Eriksson; C Andersson; C Ekerfelt; J Ernerudh; T Skogh
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

4.  Development of CD4+ T cell lines that suppress an antigen-specific immune response in vivo.

Authors:  L Vieira de Moraes; B Sun; L V Rizzo
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

5.  Abnormal Tr1 differentiation in multiple sclerosis.

Authors:  Anne L Astier; David A Hafler
Journal:  J Neuroimmunol       Date:  2007-10-22       Impact factor: 3.478

Review 6.  T-helper cell tolerance to ubiquitous nuclear antigens.

Authors:  B Nakken; K E Davis; Z J Pan; M Bachmann; A D Farris
Journal:  Scand J Immunol       Date:  2003-11       Impact factor: 3.487

Review 7.  The Th1/Th2 paradigm: still important in pregnancy?

Authors:  Gérard Chaouat
Journal:  Semin Immunopathol       Date:  2007-06       Impact factor: 11.759

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.